Logo image of CVRX

CVRX INC (CVRX) Stock Fundamental Analysis

USA - NASDAQ:CVRX - US1266381052 - Common Stock

10.72 USD
+0.37 (+3.57%)
Last: 10/28/2025, 8:00:01 PM
10.75 USD
+0.03 (+0.28%)
After Hours: 10/28/2025, 8:00:01 PM
Fundamental Rating

2

Taking everything into account, CVRX scores 2 out of 10 in our fundamental rating. CVRX was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CVRX have multiple concerns. While showing a medium growth rate, CVRX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CVRX had negative earnings in the past year.
CVRX had a negative operating cash flow in the past year.
CVRX had negative earnings in each of the past 5 years.
In the past 5 years CVRX always reported negative operating cash flow.
CVRX Yearly Net Income VS EBIT VS OCF VS FCFCVRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

CVRX has a Return On Assets of -43.70%. This is in the lower half of the industry: CVRX underperforms 62.96% of its industry peers.
CVRX has a worse Return On Equity (-90.19%) than 62.43% of its industry peers.
Industry RankSector Rank
ROA -43.7%
ROE -90.19%
ROIC N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
CVRX Yearly ROA, ROE, ROICCVRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

CVRX has a better Gross Margin (83.54%) than 93.65% of its industry peers.
In the last couple of years the Gross Margin of CVRX has grown nicely.
The Profit Margin and Operating Margin are not available for CVRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 83.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
CVRX Yearly Profit, Operating, Gross MarginsCVRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

3

2. Health

2.1 Basic Checks

CVRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CVRX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CVRX has more shares outstanding
CVRX has a worse debt/assets ratio than last year.
CVRX Yearly Shares OutstandingCVRX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CVRX Yearly Total Debt VS Total AssetsCVRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -3.88, we must say that CVRX is in the distress zone and has some risk of bankruptcy.
CVRX has a Altman-Z score of -3.88. This is in the lower half of the industry: CVRX underperforms 67.20% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that CVRX is somewhat dependend on debt financing.
CVRX has a worse Debt to Equity ratio (0.85) than 73.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z -3.88
ROIC/WACCN/A
WACC8.48%
CVRX Yearly LT Debt VS Equity VS FCFCVRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CVRX has a Current Ratio of 11.99. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
CVRX has a better Current ratio (11.99) than 95.77% of its industry peers.
CVRX has a Quick Ratio of 10.78. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 10.78, CVRX belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.99
Quick Ratio 10.78
CVRX Yearly Current Assets VS Current LiabilitesCVRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.97% over the past year.
Looking at the last year, CVRX shows a very strong growth in Revenue. The Revenue has grown by 23.11%.
Measured over the past years, CVRX shows a very strong growth in Revenue. The Revenue has been growing by 52.30% on average per year.
EPS 1Y (TTM)17.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.31%
Revenue 1Y (TTM)23.11%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%15.09%

3.2 Future

The Earnings Per Share is expected to grow by 8.33% on average over the next years. This is quite good.
The Revenue is expected to grow by 19.43% on average over the next years. This is quite good.
EPS Next Y23.03%
EPS Next 2Y13.36%
EPS Next 3Y10.67%
EPS Next 5Y8.33%
Revenue Next Year9.98%
Revenue Next 2Y14.2%
Revenue Next 3Y17.48%
Revenue Next 5Y19.43%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CVRX Yearly Revenue VS EstimatesCVRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
CVRX Yearly EPS VS EstimatesCVRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 -5 -10 -15 -20

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVRX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVRX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVRX Price Earnings VS Forward Price EarningsCVRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVRX Per share dataCVRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.36%
EPS Next 3Y10.67%

0

5. Dividend

5.1 Amount

No dividends for CVRX!.
Industry RankSector Rank
Dividend Yield N/A

CVRX INC

NASDAQ:CVRX (10/28/2025, 8:00:01 PM)

After market: 10.75 +0.03 (+0.28%)

10.72

+0.37 (+3.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners63.01%
Inst Owner Change-0.01%
Ins Owners4.33%
Ins Owner Change0.87%
Market Cap280.33M
Revenue(TTM)54.65M
Net Income(TTM)-52252000
Analysts80
Price Target11.83 (10.35%)
Short Float %7.55%
Short Ratio9.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.68%
Min EPS beat(2)-7.47%
Max EPS beat(2)8.82%
EPS beat(4)1
Avg EPS beat(4)-7.51%
Min EPS beat(4)-19.26%
Max EPS beat(4)8.82%
EPS beat(8)3
Avg EPS beat(8)-10.91%
EPS beat(12)7
Avg EPS beat(12)-4.26%
EPS beat(16)10
Avg EPS beat(16)-2.61%
Revenue beat(2)1
Avg Revenue beat(2)-4.37%
Min Revenue beat(2)-9.51%
Max Revenue beat(2)0.76%
Revenue beat(4)1
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-9.51%
Max Revenue beat(4)0.76%
Revenue beat(8)2
Avg Revenue beat(8)-1.8%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)9
Avg Revenue beat(16)0.96%
PT rev (1m)0%
PT rev (3m)-1.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.14%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-2.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.13
P/FCF N/A
P/OCF N/A
P/B 4.84
P/tB 4.84
EV/EBITDA N/A
EPS(TTM)-2.1
EYN/A
EPS(NY)-1.92
Fwd EYN/A
FCF(TTM)-1.51
FCFYN/A
OCF(TTM)-1.5
OCFYN/A
SpS2.09
BVpS2.22
TBVpS2.22
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.7%
ROE -90.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 83.54%
FCFM N/A
ROA(3y)-37.96%
ROA(5y)-32.85%
ROE(3y)-58.86%
ROE(5y)-49.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y2.79%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.27%
Cap/Sales 0.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.99
Quick Ratio 10.78
Altman-Z -3.88
F-Score3
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)167.13%
Cap/Depr(5y)316.6%
Cap/Sales(3y)2.41%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.31%
EPS Next Y23.03%
EPS Next 2Y13.36%
EPS Next 3Y10.67%
EPS Next 5Y8.33%
Revenue 1Y (TTM)23.11%
Revenue growth 3Y57.85%
Revenue growth 5Y52.3%
Sales Q2Q%15.09%
Revenue Next Year9.98%
Revenue Next 2Y14.2%
Revenue Next 3Y17.48%
Revenue Next 5Y19.43%
EBIT growth 1Y7.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.7%
EBIT Next 3Y8.9%
EBIT Next 5YN/A
FCF growth 1Y13.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.06%
OCF growth 3YN/A
OCF growth 5YN/A

CVRX INC / CVRX FAQ

Can you provide the ChartMill fundamental rating for CVRX INC?

ChartMill assigns a fundamental rating of 2 / 10 to CVRX.


What is the valuation status of CVRX INC (CVRX) stock?

ChartMill assigns a valuation rating of 0 / 10 to CVRX INC (CVRX). This can be considered as Overvalued.


What is the profitability of CVRX stock?

CVRX INC (CVRX) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for CVRX stock?

The Earnings per Share (EPS) of CVRX INC (CVRX) is expected to grow by 23.03% in the next year.